Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines-Reference-Cited by-同舟云学术

Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines

Published:2017-08-09 Issue:5 Volume:16 Page:
ISSN:1871-5273
Container-title:CNS & Neurological Disorders - Drug Targets
language:en
Short-container-title:CNSNDDT

Author:

Arellano Ana Lucia¹,Papaseit Esther²,Romaguera Anna³,Torrens Marta³,Farré Magi¹

Affiliation:

1. Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol-IGTP and Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Carretera de Canyet s/n. 08916 Badalona, Spain

2. Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol-IGTP. Carretera de Canyet s/n. 08916 Badalona, Spain

3. Drug Addiction Program, Institut de Neuropsiquiatria i Addiccions (INAD-IMIM-PSMAR) and Department of Psychiatry, Universitat Autònoma de Barcelona. Passeig Maritim 25, 08003 Barcelona, Spain

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Neuroscience

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality;International Journal of Molecular Sciences;2024-06-06

2. Current Cannabidiol Safety: A Review;Current Drug Safety;2023-11

3. Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review;Journal of Dual Diagnosis;2023-07-03

4. Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications;International Journal of Pharmacy Practice;2022-11-29

5. Important Drug-Drug Interactions for the Addiction Psychiatrist;Psychiatric Clinics of North America;2022-09